Fellgiebel, Andreas; Lieb, Klaus
NeuroenhancementFrank Erbguth, Ralf J. Jox (Hrsg). Angewandte Ethik in der Neuromedizin. Springer 2017
Kayser, S.
Neurostimulatory options for treatment resistant depression: which treatment for which patient?EUROPEAN NEUROPSYCHOPHARMACOLOGY. Bd. 27. 2017 S. S574-S574
Lieb, Klaus; Koch, Cora
No Presents even for Christmas! On the Influence of Contributions from the Pharmaceutical Industry on Prescribing BehaviorDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 142. H. 25. 2017 S. 1949-1953
Flesch, Daniel; Cheung, Sun-Yee; Schmidt, Jurema et al.
Nonacidic Farnesoid X Receptor ModulatorsJOURNAL OF MEDICINAL CHEMISTRY. Bd. 60. H. 16. 2017 S. 7199-7205
Kilimann, Ingo; Hausner, Lucrezia; Fellgiebel, Andreas et al.
Parallel Atrophy of Cortex and Basal Forebrain Cholinergic System in Mild Cognitive ImpairmentCEREBRAL CORTEX. Bd. 27. H. 3. 2017 S. 1841-1848
Paulzen, Michael; Schoretsanitis, Georgios; Stegmann, Benedikt et al.
Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychoticsPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. Bd. 76. 2017 S. 101-106
Schoretsanitis, G.; Haen, E.; Hiemke, C. et al.
Pharmacokinetic differences for risperidone between gendersEUROPEAN NEUROPSYCHOPHARMACOLOGY. Bd. 27. 2017 S. S56-S57
Schoretsanitis, G.; Haen, E.; Hiemke, C. et al.
Pharmacokinetics to rediscover psychotropics; the case of risperidoneEUROPEAN NEUROPSYCHOPHARMACOLOGY. Bd. 27. 2017 S. S547-S547
Völlm, Birgit; Stoffers-Winterling, Jutta; Lieb, Klaus
PharmakotherapieDulz, Briken, Kernberg, Rauchfleisch (Hrsg). Handbuch der Antisozialen Persönlichkeitsstörung. Schattauer 2017
Faber, Hanna; Opitz, Alexander; Mueller-Dahlhaus, Florian et al.
Polarity-independent effects of tDCS on paired associative stimulation-induced plasticityBRAIN STIMULATION. Bd. 10. H. 6. 2017 S. 1061-1069